NCT00925288 Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers Status COMPLETED Phase PHASE4
NCT00925015 Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016) Status COMPLETED Phase PHASE1
NCT00924781 A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12) Status TERMINATED Phase PHASE2
NCT00923962 Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT00918489 Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) Status COMPLETED Phase PHASE2
NCT00917696 Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00916747 Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria Status UNKNOWN Phase PHASE2
NCT00914212 A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103) Status COMPLETED Phase PHASE1
NCT00912002 A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00910624 Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) Status COMPLETED Phase PHASE3
NCT00910000 Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00908544 New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients Status COMPLETED Phase NA
NCT00907738 A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) Status COMPLETED Phase PHASE2
NCT00907517 Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) Status TERMINATED Phase PHASE1